StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > geopolitical risk

<< Previous

Bullboard Posts

Next >>

Comment by davewhoon Jan 24, 2022 9:39am

126 Views

Post# 34351870

RE:RE:geopolitical risk

VIX shows 33+ this morning.

Jan 24 (Reuters) - Wall Street's main indexes were set to fall on Monday after a bruising selloff last week, as the prospect of a Russian attack on Ukraine roiled global markets ahead of a Federal Reserve policy meeting later this week.

The U.S. State Department announced on Sunday it was ordering diplomats' family members to leave Ukraine, as U.S. President Joe Biden weighed options for boosting America's military assets in Eastern Europe to counter a buildup of Russian troops.

<< Previous

Bullboard Posts

Next >>

Get a better understanding of the psychology of options trading